ILF2 and cancer: Overexpression of RUVBL1, RUVBL2, ILF2, ILF3, and HNRNPM are observed in various cancers with their progression (RUVBL1 and RUVBL222,46, ILF2 and ILF347–49, HNRNPM50,51).